Last edition
News about "Cancer Drug Development"
Breakthru Medicine Raises USD 60 Million Series A to Advance Cancer Drugs
Founded by biotech veterans Steve Potts, Mark Mulvihill and Brian Barnett, Breakthru Medicine has raised USD 60 million in Series A funding to advance its stealth oncology pipeline, including molecular glues, small molecules and novel ADC payloads.
Cancer Drug Development | 02/02/2026 | By News Bureau
Cellectar Biosciences Partners with ITM to Secure Actinium-225 Supply for Cancer Drug Development
Cellectar Biosciences, Inc., a late-stage clinical biopharmaceutical company focused on cancer drug discovery and development, has entered into a supply agreement with ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech firm, for Actinium-225 (Ac-225).
Cancer Drug Development | 15/09/2025 | By Darshana | 196
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy